BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Buschle A, Hammerschmidt W. Epigenetic lifestyle of Epstein-Barr virus. Semin Immunopathol 2020;42:131-42. [PMID: 32232535 DOI: 10.1007/s00281-020-00792-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Bernaudat F, Gustems M, Günther J, Oliva MF, Buschle A, Göbel C, Pagniez P, Lupo J, Signor L, Müller CW, Morand P, Sattler M, Hammerschmidt W, Petosa C. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1. Nucleic Acids Res 2021:gkab1183. [PMID: 34893887 DOI: 10.1093/nar/gkab1183] [Reference Citation Analysis]
2 Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol 2020;11:587380. [PMID: 33488588 DOI: 10.3389/fimmu.2020.587380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
3 Petrova-Drus K, Quesada AE, Bowman AS, Ptashkin R, Yao J, Arcila ME, Ho C, Moung C, Regalado J, Benayed R, Benhamida JK, Galera PK, Dogan A, Vanderbilt C. Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation Sequencing. J Mol Diagn 2022;24:69-78. [PMID: 34801704 DOI: 10.1016/j.jmoldx.2021.10.009] [Reference Citation Analysis]
4 Dochnal SA, Francois AK, Cliffe AR. De Novo Polycomb Recruitment: Lessons from Latent Herpesviruses. Viruses 2021;13:1470. [PMID: 34452335 DOI: 10.3390/v13081470] [Reference Citation Analysis]
5 Caruso LB, Guo R, Keith K, Madzo J, Maestri D, Boyle S, Wasserman J, Kossenkov A, Gewurz BE, Tempera I. The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. PLoS Pathog 2022;18:e1010400. [PMID: 35421198 DOI: 10.1371/journal.ppat.1010400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Di Pietro A. Epstein-Barr Virus Promotes B Cell Lymphomas by Manipulating the Host Epigenetic Machinery. Cancers (Basel) 2020;12:E3037. [PMID: 33086505 DOI: 10.3390/cancers12103037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Pietropaolo V, Prezioso C, Moens U. Role of Virus-Induced Host Cell Epigenetic Changes in Cancer. Int J Mol Sci 2021;22:8346. [PMID: 34361112 DOI: 10.3390/ijms22158346] [Reference Citation Analysis]
8 Fischer N. Infection-induced epigenetic changes and their impact on the pathogenesis of diseases. Semin Immunopathol 2020;42:127-30. [PMID: 32318841 DOI: 10.1007/s00281-020-00793-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Xia W, Chen H, Feng Y, Shi N, Huang Z, Feng Q, Jiang X, He G, Xie M, Lai Y, Wang Z, Yi X, Tang A. Tree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus. Front Immunol 2021;12:789604. [PMID: 35111158 DOI: 10.3389/fimmu.2021.789604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bouvet M, Voigt S, Tagawa T, Albanese M, Chen YA, Chen Y, Fachko DN, Pich D, Göbel C, Skalsky RL, Hammerschmidt W. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus. mBio 2021;12:e03440-20. [PMID: 33785626 DOI: 10.1128/mBio.03440-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V. Viral Infections and Systemic Lupus Erythematosus: New Players in an Old Story. Viruses 2021;13:277. [PMID: 33670195 DOI: 10.3390/v13020277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yiu SPT, Guo R, Zerbe C, Weekes MP, Gewurz BE. Epstein-Barr virus BNRF1 destabilizes SMC5/6 cohesin complexes to evade its restriction of replication compartments. Cell Rep 2022;38:110411. [PMID: 35263599 DOI: 10.1016/j.celrep.2022.110411] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chase Huizar C, Raphael I, Forsthuber TG. Genomic, proteomic, and systems biology approaches in biomarker discovery for multiple sclerosis. Cell Immunol 2020;358:104219. [PMID: 33039896 DOI: 10.1016/j.cellimm.2020.104219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies. Viruses 2022;14:1017. [DOI: 10.3390/v14051017] [Reference Citation Analysis]
15 Zhang Y, Jiang C, Trudeau SJ, Narita Y, Zhao B, Teng M, Guo R, Gewurz BE. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation. mBio 2020;11:e01063-20. [PMID: 33109754 DOI: 10.1128/mBio.01063-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Slabik C, Kalbarczyk M, Danisch S, Zeidler R, Klawonn F, Volk V, Krönke N, Feuerhake F, Ferreira de Figueiredo C, Blasczyk R, Olbrich H, Theobald SJ, Schneider A, Ganser A, von Kaisenberg C, Lienenklaus S, Bleich A, Hammerschmidt W, Stripecke R. CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease. Mol Ther Oncolytics 2020;18:504-24. [PMID: 32953984 DOI: 10.1016/j.omto.2020.08.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Soldan SS, Su C, Lamontagne RJ, Grams N, Lu F, Zhang Y, Gesualdi JD, Frase DM, Tolvinski LE, Martin K, Messick TE, Fingerut JT, Koltsova E, Kossenkov A, Lieberman PM. Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes. PLoS Pathog 2021;17:e1009618. [PMID: 34106998 DOI: 10.1371/journal.ppat.1009618] [Reference Citation Analysis]